The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/287208
OUTSOURCING INSIGHTS REPORT If you want to learn more about the report or about how to participate, please contact Nigel Walker, managing director, or Salvatore Fazzolari, director of client services, at Nice Insight by sending an email to niceinsight.survey@thatsnice.com . N . W A L K E R S . F A Z Z O L A R I APRIL 2014 LIFESCIENCELEADER.COM 18 Survey Methodology: Nice Insight CMO Strategy surveys are deployed on behalf of Nice Insight clients to a targeted group of outsourcing decision makers. The surveys comprise of ~40 questions geared toward under- standing current outsourcing practices, present and future expectations from outsourcing partners, and which traits contribute to successful partnerships. [n=200] the 42 percent who will outsource fill- finish projects in the coming year. When it comes to the product types of interest, there is a demand for advanced functionality, such as controlled or extended release, but survey respon- dents agreed their company's product focus still leans toward tablets and cap- sules. This isn't too surprising consider- ing stick-pack technology is relatively new to the U.S. market, especially when it comes to prescription drugs. However, as outsourcing models evolve toward part- nerships where biopharmaceutical com- panies expect CMOs to add value beyond reducing fixed costs, offering new tech- nologies that are consumer-friendly and ensure accurate dosing is a way for both brands (sponsor and CMO) to gain cus- tomer loyalty. Specialized delivery tech- nology can cement biopharmaceutical customers into long-term relationships with their contract manufacturer, and user-friendly packaging that facilitates accurate dosing strongly appeals to con- sumers. These methods will aid in cap- turing market share as well as building brand loyalty among consumers. The good news is that drug makers in North America will soon have wider access to manufacturers of medications in stick-pack format, which will in turn increase availability to consumers. An established European leader in unit-dose manufacturing, Unither, has plans to open the first liquid stick-pack line in the U.S. this summer, which will join Ropack and PNP Pharmaceuticals (part of NSF), both based out of Canada, to further serve the market. L Does the company you work for offer any of the following specialized formulations? Formulations for Special Needs Patients Pediatric Formulations Geriatric Formulations When engaging a CMO for f ll-f nish, which of the following types of products is your company interested in producing? Controlled release tablets Orally disintegrating tablets Extended release oral suspensions Immediate release f lled capsules Immediate release tablets Controlled release f lled capsules Immediate release oral suspensions Immediate release oral solutions Powder f lled capsules Resin or bead f lled capsules Stick-pack single unit dose for liquids Blow-f ll-seal sterile single unit dose Stick-pack single unit dose for powders 62% 73% 56% 53% 55% 50% 55% 54% 49% 46% 45% 44% 33% 33% 30% 24% By K. Hammeke NEW TECHNOLOGIES IN FILL-FINISH MAY BRING BRAND LOYALTY ALONG WITH IMPROVED PATIENT SAFETY Please select the answer below that best f ts your company's level of consumer focus with regards to its drug development efforts. Very consumer focused / Our company actively seeks information on the buyers of our products and it heavily inf uences our product development 44% 39% 14% 3% Somewhat consumer focused / Our company knows a fair amount about the buyers of our products and that information has some inf uence on our product development Neither consumer focused nor nonconsumer focused / Our company knows some information about the buyers of our products, but it does not inf uence our product development Not at all consumer focused / Our company knows very little, if anything, about the buyers of our products 0 4 1 4 _ R e p o r t s _ O I . i n d d 2 0414_Reports_OI.indd 2 3 / 2 1 / 2 0 1 4 1 2 : 2 1 : 1 9 P M 3/21/2014 12:21:19 PM